Three‐year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open‐angle glaucoma: a multicentre study [PDF]
Acta ophthalmologica, 2021 To assess the 3‐year effectiveness and safety of the XEN gel stent implanted ab interno in open‐angle glaucoma (OAG).
Herbert A. Reitsamer +10 more
openalex +2 more sources
Neuroinflammation in Primary Open-Angle Glaucoma [PDF]
Journal of Clinical Medicine, 2020 Primary open-angle glaucoma (POAG) is the second leading cause of irreversible blindness worldwide. Increasing evidence suggests oxidative damage and immune response defects are key factors contributing to glaucoma onset.
S. Vernazza +4 more
semanticscholar +3 more sources
Canaloplasty in the Treatment of Open-Angle Glaucoma: A Review of Patient Selection and Outcomes. [PDF]
Advances in Therapy, 2018 Canaloplasty is a relatively new non-penetrating surgery for the reduction of intraocular pressure in patients affected by glaucoma. The technique uses a microcatheter to perform a 360 º cannulation of Schlemm's canal and leaves in place a tension suture
Brusini, Paolo +5 more
core +3 more sources
Effect of mean ocular perfusion pressure on primary open angle glaucoma
Bangabandhu Sheikh Mujib Medical University Journal, 2018 Primary open angle glaucoma is the most common form of glaucoma and it remains asymptomatic until the late stage of the disease. The purpose of this study is to compare the mean ocular perfusion pressure with the primary open angle glaucoma.
Pallab Kumar Sen +2 more
doaj +3 more sources
Minimally Invasive Glaucoma Surgical Techniques for Open-Angle Glaucoma
JAMA ophthalmology, 2021 Amanda K. Bicket +14 more
openalex +3 more sources
Effect of antioxidants on primary open-angle glaucoma: a systematic review and meta-analysis [PDF]
Frontiers in PharmacologyBackground/ObjectivesPrimary open-angle glaucoma is a major global cause of vision loss, severely impacting quality of life. Although the need for effective treatments is widely recognized, the efficacy and safety of antioxidants remain uncertain.
Jie Bao +5 more
doaj +2 more sources
Glaukos iStent inject® Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients with Coexisting Cataract and Open-Angle Glaucoma or Ocular Hypertension: A Long-Term Study [PDF]
Journal of Ophthalmology, 2016 Purpose. To evaluate the long-term efficacy and safety of the iStent inject device (Glaukos Corporation, Laguna Hills, CA) combined with phacoemulsification in patients with coexistent cataract and open-angle glaucoma or ocular hypertension (OHT ...
Arriola Villalobos, Pedro +5 more
core +9 more sources
Hypertension in Primary Open Angle Glaucoma
Journal of Nepal Medical Association, 2014 Introduction: The impact of vascular factors in POAG is well known and controversial. Some reports have shown high blood pressure in POAG, some low systolic blood pressure and some described no difference in blood pressure between POAG and controls ...
Suprada Pokharel +2 more
doaj +6 more sources
Medical treatment of open-angle glaucoma [PDF]
Community Eye Health Journal, 2012 Most guidelines that exist for the treatment of primary open-angle glaucoma (POAG) – such the National Institute for Health and Clinical Excellence (NICE) guidelines (page 47) – recommend medicine as initial therapy, though laser treatment may also play ...
Mohammed M Abdull +3 more
doaj +4 more sources
Effect of Glaucoma on Corneal Endothelium [PDF]
Egyptian Journal of Medical Research, 2021 Background: Glaucoma is a group of diseases characterized by a specific pattern of optic nerve neuropathy and retinopathy which is permenant. There is increasing evidence of glaucoma-associated corneal endothelial changes.
Hazem Effat Abd El-Ghany Mohammad Haroon +3 more
doaj +1 more source